Dr. Iram Mall, M.B.B.S
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,896 | 437 | 99.3% |
| Education | $50.00 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $964.98 | 72 | $0 (2024) |
| GlaxoSmithKline, LLC. | $896.06 | 56 | $0 (2024) |
| Novo Nordisk Inc | $881.64 | 63 | $0 (2024) |
| PFIZER INC. | $534.01 | 29 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $475.34 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $334.47 | 21 | $0 (2024) |
| Lilly USA, LLC | $319.43 | 18 | $0 (2024) |
| Amgen Inc. | $298.10 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $274.82 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $206.15 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,459 | 90 | ABBVIE INC. ($299.92) |
| 2023 | $1,007 | 53 | GlaxoSmithKline, LLC. ($230.67) |
| 2022 | $1,572 | 94 | ABBVIE INC. ($315.29) |
| 2021 | $807.61 | 57 | AbbVie Inc. ($299.68) |
| 2020 | $421.93 | 29 | Novo Nordisk Inc ($176.73) |
| 2019 | $482.99 | 37 | Novo Nordisk Inc ($147.50) |
| 2018 | $1,042 | 68 | PFIZER INC. ($208.67) |
| 2017 | $153.94 | 11 | Novo Nordisk Inc ($36.42) |
All Payment Transactions
439 individual payment records from CMS Open Payments — Page 2 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardio-renal | ||||||
| 09/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: UROLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PAIN | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes Care | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: Cardiovascular | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.52 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 736 | 1,110 | $187,483 | $43,418 |
| 2022 | 15 | 751 | 1,071 | $164,899 | $38,505 |
| 2021 | 14 | 583 | 678 | $95,058 | $45,626 |
| 2020 | 13 | 620 | 905 | $111,526 | $42,544 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 50 | 61 | $2,013 | $644.88 | 32.0% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 12 | 12 | $1,260 | $507.70 | 40.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 107 | 158 | $2,370 | $468.66 | 19.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 20 | 20 | $996.00 | $324.41 | 32.6% |
| 81003 | Automated urinalysis test | Office | 2020 | 48 | 54 | $378.00 | $118.65 | 31.4% |
About Dr. Iram Mall, M.B.B.S
Dr. Iram Mall, M.B.B.S is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1538573514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iram Mall, M.B.B.S has received a total of $6,946 in payments from pharmaceutical and medical device companies, with $1,459 received in 2024. These payments were reported across 439 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,896).
As a Medicare-enrolled provider, Mall has provided services to 2,690 Medicare beneficiaries, totaling 3,764 services with total Medicare billing of $170,092. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Albany, NY
- Active Since 06/17/2014
- Last Updated 03/17/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1538573514
Products in Payments
- TRELEGY ELLIPTA (Drug) $698.91
- UBRELVY (Drug) $521.56
- Saxenda (Drug) $375.49
- JARDIANCE (Drug) $351.20
- QULIPTA (Drug) $340.14
- Ozempic (Drug) $333.71
- NURTEC ODT (Drug) $293.07
- ELIQUIS (Drug) $226.98
- FARXIGA (Drug) $219.58
- XARELTO (Drug) $198.97
- MOUNJARO (Drug) $146.73
- JANUVIA (Drug) $140.93
- VRAYLAR (Drug) $137.50
- ZENPEP (Drug) $137.20
- Otezla (Drug) $134.01
- XIFAXAN (Drug) $131.99
- LEQVIO (Drug) $125.84
- SHINGRIX (Biological) $116.89
- CHANTIX (Drug) $115.55
- EUCRISA (Drug) $110.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
Dr. Erica Parrotta, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $111,723
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736